102 related articles for article (PubMed ID: 1742211)
1. Hydronephrosis: prevention by restoration of urinary concentrating ability using desamino-8D-arginine vasopressin (DDAVP) in Brattleboro rats.
Laycock JF; Barrett MC; Woodrow DF
Int J Exp Pathol; 1991 Oct; 72(5):581-7. PubMed ID: 1742211
[TBL] [Abstract][Full Text] [Related]
2. The abnormal quinine drinking aversion in the Brattleboro rat with diabetes insipidus is reversed by the vasopressin agonist DDAVP: a possible role for vasopressin in the motivation to drink.
Laycock JF; Chatterji U; Seckl JR; Gartside IB
Physiol Behav; 1994 Mar; 55(3):407-12. PubMed ID: 8190753
[TBL] [Abstract][Full Text] [Related]
3. Regulation of acid-base transporters by vasopressin in the kidney collecting duct of Brattleboro rat.
Amlal H; Sheriff S; Faroqui S; Ma L; Barone S; Petrovic S; Soleimani M
Am J Nephrol; 2006; 26(2):194-205. PubMed ID: 16699257
[TBL] [Abstract][Full Text] [Related]
4. [Urinary concentration capacity in neonatal hydronephrosis].
Orejas Rodríguez-Arango G; García Vicente S; Rey Galán C; Ramos Aparicio A; Santos Rodríguez F; Málaga Guerrero S
An Esp Pediatr; 1993 Jan; 38(1):10-2. PubMed ID: 8439070
[TBL] [Abstract][Full Text] [Related]
5. Atrial natriuretic peptide and its mRNA in heart and brain of vasopressin-deficient Brattleboro rats.
Arjamaa O; Taskinen T; Kanervo A; Vuolteenaho O; Leppäluoto J
Acta Physiol Scand; 1995 May; 154(1):35-42. PubMed ID: 7572200
[TBL] [Abstract][Full Text] [Related]
6. Vasopressin induces expression of the Cl-/HCO3- exchanger SLC26A7 in kidney medullary collecting ducts of Brattleboro rats.
Petrovic S; Amlal H; Sun X; Karet F; Barone S; Soleimani M
Am J Physiol Renal Physiol; 2006 May; 290(5):F1194-201. PubMed ID: 16352747
[TBL] [Abstract][Full Text] [Related]
7. The urinary excretion of selenium in sheep treated with a vasopressin analogue.
Leng L; Boldizárová K; Faix S; Kovác G
Vet Res; 2000; 31(5):499-505. PubMed ID: 11050745
[TBL] [Abstract][Full Text] [Related]
8. [Experiences with intranasal and parenteral use of 1-desamino-8-D-arginine vasopressin (DDAVP). Use in a simple test of renal concentrating ability].
Tuschy U; Szeszat S; Rindfleisch U
Z Gesamte Inn Med; 1984 Jun; 39(11):265-8. PubMed ID: 6475171
[TBL] [Abstract][Full Text] [Related]
9. Oral antidiuretic therapy: studies in the diabetes insipidus rat.
Kinter LB; Beeuwkes R
Am J Physiol; 1982 Nov; 243(5):R491-9. PubMed ID: 7137378
[TBL] [Abstract][Full Text] [Related]
10. DDAVP (1-desamino-8-D-arginine-vasopressin) treatment of lithium-induced polyuria in the rat.
Christensen S
Scand J Clin Lab Invest; 1980 Apr; 40(2):151-7. PubMed ID: 7256183
[TBL] [Abstract][Full Text] [Related]
11. Dose-dependent stimulation of renal prostaglandin synthesis by deamino-8-D-arginine vasopressin in rats with hereditary diabetes insipidus.
Walker LA; Frölich JC
J Pharmacol Exp Ther; 1981 Apr; 217(1):87-91. PubMed ID: 7205662
[TBL] [Abstract][Full Text] [Related]
12. Desamino-8D-arginine vasopressin treatment of Brattleboro rats: effect on sensitivity to pressor hormones.
Laycock JF
Eur J Pharmacol; 1994 Dec; 271(1):193-9. PubMed ID: 7698201
[TBL] [Abstract][Full Text] [Related]
13. Biological half-lives and organ distribution of tritiated 8-lysine-vasopressin and 1-deamino-8-D-arginine-vasopressin in Brattleboro rats.
Janáky T; Laczi F; László FA
Ann N Y Acad Sci; 1982; 394():116-27. PubMed ID: 6960751
[TBL] [Abstract][Full Text] [Related]
14. Desamino arginine vasopressin (DDAVP) as a diagnostic agent.
Somerfield SD; Hocken AG
N Z Med J; 1977 Nov; 86(600):472-3. PubMed ID: 343010
[TBL] [Abstract][Full Text] [Related]
15. Effect of vasopressin on the expression of genes for key enzymes of hyaluronan turnover in Wistar Albino Glaxo and Brattleboro rat kidneys.
Ivanova LN; Babina AV; Baturina GS; Katkova LE
Exp Physiol; 2013 Nov; 98(11):1608-19. PubMed ID: 23955305
[TBL] [Abstract][Full Text] [Related]
16. 1-desamino-8-D-arginine vasopressin (DDAVP) concentration test.
Radó JP
Am J Med Sci; 1978; 275(1):43-52. PubMed ID: 665711
[TBL] [Abstract][Full Text] [Related]
17. Hemodynamic and coagulation responses to 1-desamino[8-D-arginine] vasopressin in patients with congenital nephrogenic diabetes insipidus.
Bichet DG; Razi M; Lonergan M; Arthus MF; Papukna V; Kortas C; Barjon JN
N Engl J Med; 1988 Apr; 318(14):881-7. PubMed ID: 2965301
[TBL] [Abstract][Full Text] [Related]
18. Stability of the vasopressin V2 receptor-adenylyl cyclase system in rat kidney.
Shen T; Laycock J; Suzuki Y; Defer N; Hanoune J
Eur J Pharmacol; 1998 Jan; 341(1):87-94. PubMed ID: 9489860
[TBL] [Abstract][Full Text] [Related]
19. Axial heterogeneity in basolateral AQP2 localization in rat kidney: effect of vasopressin.
Christensen BM; Wang W; Frøkiaer J; Nielsen S
Am J Physiol Renal Physiol; 2003 Apr; 284(4):F701-17. PubMed ID: 12453871
[TBL] [Abstract][Full Text] [Related]
20. [Experiences with intranasal and parenteral use of 1-desamino-8-D-arginine vasopressin (DDAVP). Use in the diagnosis of hypophyseal function].
Tuschy U; Szeszat S; Meinhold J
Z Gesamte Inn Med; 1983 Sep; 38(17):475-7. PubMed ID: 6636917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
